Acrivon Therapeutics, Inc.
ACRV
Revenue
0.00
0.000.00%
-Assets
230.59M
▲110.06M▲91.32%
3 Months ChangeLiabilities
14.53M
▲1.99M▲15.83%
3 Months ChangeFree Cash Flow
-17.90M
▼-6.52M▼-57.25%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-11
Form 8-K
ID: 0000950170-24-114213
2024-09-16
Form 8-K
ID: 0001193125-24-219180
2024-08-13
Form 8-K
ID: 0000950170-24-095766
2024-08-13
Form 10-Q
ID: 0000950170-24-095760
2024-06-21
Form 8-K
ID: 0000950170-24-075760
2024-05-14
Form 8-K
ID: 0000950170-24-059097
2024-05-14
Form 10-Q
ID: 0000950170-24-059084
2024-04-24
Form 8-K
ID: 0000950170-24-047560
2024-04-09
Form 8-K
ID: 0000950170-24-042789
2024-03-28
Form 8-K
ID: 0000950170-24-037627